Murilo Freitas – Página 431

A proibição levou em consideração o recolhimento voluntário promovido pela empresa, em decorrência da utilização de matéria-prima vencida na fabricação dos produtos

http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5091444

https://www.canada.ca/en/health-canada/news/2018/11/the-governments-of-canada-and-saskatchewan-will-announce-new-measures-to-increase-access-to-treatment-for-substance-use-disorder.html rss rss-es rss-pt

The Governments of Canada and Saskatchewan will announce new measures to increase access to treatment for substance use disorder

Murilo Freitas - 17:56, 8 de noviembre de 2018698

The Governments of Canada and Saskatchewan will announce new measures to increase access to treatment for substance use disorder

https://www.canada.ca/en/health-canada/news/2018/11/the-governments-of-canada-and-saskatchewan-will-announce-new-measures-to-increase-access-to-treatment-for-substance-use-disorder.html

rss rss-es rss-pt

RCSS: Anvisa participa de reunião no Peru

Murilo Freitas - 17:14, 8 de noviembre de 2018829

Reunião Anual Ordinária da Plenária da Rede Consumo Seguro e Saúde (RCSS) aconteceu nos dias 30 e 31 de outubro, no Peru

http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5091071

rss-es

Job Opportunity at PAHO: Chief, Strategic Fund for Public Health Supplies – (1805304)

Murilo Freitas - 16:45, 8 de noviembre de 20181,280

Grade: P5
Contractual Arrangement: Fixed-term appointment
Contract duration: Two years, first year probationary period.
Job Posting: Oct 26, 2018, 4:42:46 PM
Closing Date: Nov 16, 2018, 6:59:00 PM
Primary Location: United States-Washington, D.C.
Organization: Health Systems and Services
Link: http://bit.ly/2JshPEi

rss rss-es rss-pt

ISP participó en el curso de farmacia antroposófica

Murilo Freitas - 15:57, 8 de noviembre de 2018861

http://www.ispch.cl/noticia/27351

rss rss-es rss-pt

Seguridad y eficacia del uso de regorafenib para el tratamiento de cáncer colorrectal metastásico con progresión de enfermedad al menos a dos líneas de quimioterapia previa

Murilo Freitas - 00:00, 8 de noviembre de 2018733

Seguridad y eficacia del uso de regorafenib para el tratamiento de cáncer colorrectal metastásico con progresión de enfermedad al menos a dos líneas de quimioterapia previa
http://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.964075

rss rss-es rss-pt

Eficacia y seguridad de omalizumab en niños y adolescentes con diagnóstico de asma alérgica severa no controlada

Murilo Freitas - 00:00, 8 de noviembre de 2018780

Eficacia y seguridad de omalizumab en niños y adolescentes con diagnóstico de asma alérgica severa no controlada
http://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.964071